Predictive biomarkers needed for combination treatments in kidney cancer
In this interview with OncLive, Dr Ulka Vaishampayan from Wayne [...]
PARP inhibitors, vaccines and combination therapies for kidney cancer
In this interview with OncLive, professor Sumanta Kumar Pal from [...]
Renal mass biopsy in the management of kidney cancer
A review of the evolving field of the management of [...]
Bone-targeted therapies may improve survival in metastatic kidney cancer patients
A recent study published in the journal Translational Oncology suggests [...]
Body mass index may impact survival in patients with kidney cancer
A recent paper published in the journal Lancet Oncology provides [...]
Hereditary leiomyomatosis and renal cell carcinoma (HLRCC)
Hereditary leiomyomatosis and renal cell cancer (HLRCC) is a hereditary condition associated [...]
Regular exercise reduces risk for 7 different cancers
A new study published in Journal of Clinical Oncology suggests [...]
Radiofrequency ablation and systemic treatment for kidney cancer lung metastases
A recent study published in BMC Cancer reports on the [...]
Fat near kidney tumours plays a critical role in treatment response
It is already known that obesity increases the risk of [...]
Could the anti-cancer gene p53 be a target in treating kidney cancer?
A recent paper published in the journal Nature Communications reports [...]
